Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies
2019 · Cancer Cell · 1,057 citations
https://doi.org/10.1016/j.ccell.2019.02.001
X
Xin Hu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
210
Papers
4.7K
Citations
34
h-index
69
i10-index
Xin Hu is an academic researcher from Shihezi University. The author has contributed to research in topics: CRISPR and Genetic Engineering & Cancer Genomics and Diagnostics & Breast Cancer Treatment Studies. The author has an h-index of 34, co-authored 179 publications.
ORCID: 0000-0002-8160-8362Papers by this author
worksImpact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study
2017 · Scientific Reports · 242 citations
https://doi.org/10.1038/srep45411
Bulk and single-cell transcriptome profiling reveal the metabolic heterogeneity in human breast cancers
2021 · Molecular Therapy · 109 citations
https://doi.org/10.1016/j.ymthe.2021.03.003
Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II Trial
2022 · Clinical Cancer Research · 89 citations
https://doi.org/10.1158/1078-0432.ccr-21-4313
NBA1/MERIT40 and BRE Interaction Is Required for the Integrity of Two Distinct Deubiquitinating Enzyme BRCC36-containing Complexes
2011 · Journal of Biological Chemistry · 72 citations
https://doi.org/10.1074/jbc.m110.200857
Racial/ethnic differences in the outcomes of patients with metastatic breast cancer: contributions of demographic, socioeconomic, tumor and metastatic characteristics
2018 · Breast Cancer Research and Treatment · 70 citations
https://doi.org/10.1007/s10549-018-4956-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat